HomeMARKSANS • NSE
add
Marksans Pharma Ltd
Previous close
₹250.21
Day range
₹245.71 - ₹249.60
Year range
₹130.00 - ₹358.70
Market cap
111.50B INR
Avg Volume
1.33M
P/E ratio
29.29
Dividend yield
0.24%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.25B | 29.46% |
Operating expense | 2.80B | 64.43% |
Net income | 905.46M | 15.66% |
Net profit margin | 12.49 | -10.66% |
Earnings per share | — | — |
EBITDA | 1.32B | 30.66% |
Effective tax rate | 21.85% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.05B | 0.52% |
Total assets | 32.40B | 20.84% |
Total liabilities | 7.50B | 26.08% |
Total equity | 24.89B | — |
Shares outstanding | 452.73M | — |
Price to book | 4.59 | — |
Return on assets | — | — |
Return on capital | 11.24% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 905.46M | 15.66% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1992
Website
Employees
1,141
